VDRM — Viaderma Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $13.50m
- $19.59m
- $19.01m
Annual income statement for Viaderma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2007 December 31st | R2008 December 31st | 2009 December 31st | 2010 December 31st | 2011 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.018 | 25.7 | 25.3 | 26.8 | 19 |
| Cost of Revenue | |||||
| Gross Profit | — | 10.6 | 11 | 10.1 | 5.66 |
| Selling / General / Administrative Expenses | |||||
| Total Operating Expenses | 0.159 | 16.7 | 18.9 | 19.1 | 15 |
| Operating Profit | -0.141 | 9.01 | 6.39 | 7.77 | 4.04 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.141 | 8.72 | 6.07 | 6.5 | 3.55 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.141 | 6.55 | 4.09 | 4.51 | 2.67 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.141 | 6.55 | 4.09 | 4.51 | 2.67 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.141 | 6.55 | 4.09 | 4.51 | 2.67 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -12.4 | 49.1 | 29.6 | 32.8 | 19.5 |
| Dividends per Share |